Commentary: Treatment of lichen planopilaris. Some progress, but a long way to go

Journal of the American Academy of Dermatology

Volumn 62, Issue 3, 2010, Pages 398-401

  Sperling, Leonard C ^a   Nguyen, Jennifer V ^b  

^a Uniformed Services University of the Health Sciences   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cicatricial alopecia; hydroxychloroquine; lichen planopilaris; mycophenolate mofetil; treatment

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; DOXYCYCLINE; ETRETIN; ETRETINATE; GRISEOFULVIN; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; MINOXIDIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; RETINOID DERIVATIVE; TACROLIMUS; TETRACYCLINE DERIVATIVE; THALIDOMIDE;

ALOPECIA; CLINICAL RESEARCH; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LICHEN PLANOPILARIS; LICHEN PLANUS; PRIORITY JOURNAL; SCORING SYSTEM; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; ALOPECIA; CLINICAL TRIALS AS TOPIC; CYCLOSPORINE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LICHEN PLANUS; MALE; SCALP DERMATOSES; SEVERITY OF ILLNESS INDEX;

EID: 76349125082     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.10.025     Document Type: Editorial

References (24)

1. Oxford Center for Evidence-based Medicine (2009). Oxford Centre for Evidence-based Medicine - Levels of Evidence. Available from: http://www.cebm.net. Accessed September 29, 2009.
2. Chieregato C., Zini A., Barba A., Magnanini M., and Rosina P. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol 42 (2003) 342-345
3. Mehregan D.A., van Hale H.M., and Muller S.A. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol 27 (1992) 935-942
4. Cevasco N.C., Bergfeld W.F., Remzi B.K., and de Knott H.R. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol 57 (2007) 47-53
5. Assouly P., and Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg 28 (2009) 3-10
6. Volz T., Caroli U., Lüdtke H., Bräutigam M., Kohler-Späth H., Röcken M., et al. Pimecrolimus cream 1% in erosive oral lichen planus-a prospective randomized double-blind vehicle-controlled study. Br J Dermatol 159 (2008) 936-941
7. Mirmirani P., Willey A., and Price V.H. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol 49 (2003) 667-671
8. Blazek C., and Megahed M. Lichen planopilaris: successful treatment with tacrolimus. [German]. Hautarzt 59 (2008) 874-877
9. Scalvenzi M., De Natale F., Forgione P., Russo N., and Delfino M. Topical cyclosporin A in the treatment of lichen planopilaris. Ann Ital Dermatol Clin Sper 52 (1998) 37-40
10. Spencer L.A., Hawryluk E.B., and English III J.C. Lichen planopilaris: retrospective study and stepwise therapeutic approach. Arch Dermatol 145 (2009) 333-334
11. Tan E., Martinka M., Ball N., and Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol 50 (2004) 25-32
12. Jouanique C, Reygagne P, Assouly P, Matard B, Marechal E, Bachelez H, et al. Hydroxychloroquine sulphate's ineffectiveness in the treatment of lichen planopilaris and idiopathic pseudopelade. Research abstract presented at: Third Intercontinental Meeting of Hair Research Societies; June 13-15, 2001; Tokyo, Japan.
13. Bianchi L., Paro Vidolin A., Piemonte P., Carboni I., and Chimenti S. Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A. Clin Exp Dermatol 26 (2001) 518-520
14. Boyd A.S., and King Jr. L.E. Thalidomide-induced remission of lichen planopilaris. J Am Acad Dermatol 47 (2002) 967-968
15. Doherty S.D., and Hsu S. A case series of 48 patients treated with thalidomide. J Drugs Dermatol 7 (2008) 769-773
16. George S.J., and Hsu S. Lichen planopilaris treated with thalidomide. J Am Acad Dermatol 45 (2001) 965-966
17. Jouanique C., Reygagne P., Bachelez H., and Dubertret L. Thalidomide is ineffective in the treatment of lichen planopilaris. J Am Acad Dermatol 51 (2004) 480-481
18. Tursen U., Api H., Kaya T., and Ikizoglu G. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J 10 (2004) 24
19. Laurberg G., Geiger J.M., Hjorth N., Holm P., Hou-Jensen K., Jacobsen K.U., et al. Treatment of lichen planus with acitretin: a double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol 24 (1991) 434-437
20. Ott F., Bollag W., and Geiger J.M. Efficacy of oral low-dose tretinoin (all- trans-retinoic acid) in lichen planus. Dermatology 192 (1996) 334-336
21. Massa M.C., and Rogers III R.S. Griseofulvin therapy of lichen planus. Acta Derm Venereol 61 (1981) 547-550
22. Stefanidou M.P., Ioannidou D.J., Panayiotides J.G., and Tosca A.D. Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus. Br J Dermatol 141 (1999) 1040-1045
23. Chiang C., Sah D., Cho B.K., Ochoa B.E., and Price V.H. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol 62 (2010) 387-920
24. Cho B.K., Sah D., Chwalek J., Roseborough I., Ochoa B.E., Chiang C., et al. Efficacy and safety of mycophenolate mofetil for lichen planopilaris. J Am Acad Dermatol 62 (2010) 393-397